Brookstone Capital Management’s Medifast MED Stock Holding History

Brookstone Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,142	Closed	-$209K	–	853
2023 Q1	$209K	Sell	2,142 -818	-28%	-$90.7K	﹤0.01%	778
2022 Q4	$354K	Sell	2,960 -1,212	-29%	-$141K	0.01%	664
2022 Q3	$504K	Buy	4,172 +162	+4%	+$23.2K	0.01%	563
2022 Q2	$707K	Buy	4,010 +2,775	+225%	+$496K	0.02%	493
2022 Q1	$225K	Sell	1,235 -610	-33%	-$115K	﹤0.01%	706
2021 Q4	$396K	Buy	1,845 +82	+5%	+$16.9K	0.01%	567
2021 Q3	$336K	Buy	1,763 +30	+2%	+$7.38K	0.01%	576
2021 Q2	$479K	Buy	+1,733	New	+$470K	0.01%	489

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Brookstone Capital Management's MED Position: Q2 2023 in Review

Brookstone Capital Management sold out of Medifast (MED) in Q2 2023, closing a stake of 2,142 shares — an estimated $209K sold.

Brookstone Capital Management first reported a position in MED in Q2 2021 and held it in 8 quarters. The position peaked at $707K in Q2 2022. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Brookstone Capital Management reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Brookstone Capital Management sold 2,142 Medifast shares in Q2 2023, an estimated $209K.
Brookstone Capital Management first reported a position in Medifast in Q2 2021 and held it in 8 quarters.
Brookstone Capital Management's Medifast position peaked at $707K in Q2 2022.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Brookstone Capital Management's 13F filing for Q2 2023, filed 11 Jul 2023.